Home NDC 67253-183 Ampicillin
Product NDC 67253-183
11-digit product format 672530183
Labeler code 67253
Product ID 67253-183_781ed9b9-e0ee-499b-8dc2-be2781091f42
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Ampicillin
Dosage form SUSPENSION
Route ORAL
Labeler Par Pharmaceutical
Application ANDA062982
Marketing category ANDA
Marketing start 1989-02-10
Marketing end 2020-08-31
Substance AMPICILLIN TRIHYDRATE
Active strength 50 mg/mL
Pharmacologic classes Penicillin-class Antibacterial [EPC],Penicillins [CS]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 72 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A062982-001 AMPICILLIN TRIHYDRATE AMPICILLIN/AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 A062982-002 AMPICILLIN TRIHYDRATE AMPICILLIN/AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 86 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 84e616aacf4f…2026-08-18 06:07:40 2026-07 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A062982-001 AMPICILLIN TRIHYDRATE EQ 125MG BASE/5ML FOR SUSPENSION / ORAL 1989-02-10 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A062982-002 AMPICILLIN TRIHYDRATE EQ 250MG BASE/5ML FOR SUSPENSION / ORAL RS 1989-02-10 74a2ff9319b5…
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded AMPICILLIN TRIHYDRATE ACTIVE INGREDIENT HXQ6A1N7R6 AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 AMPICILLIN ACTIVE MOIETY 7C782967RD AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM INACTIVE INGREDIENT K679OBS311 AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 D&C RED NO. 28 INACTIVE INGREDIENT 767IP0Y5NH AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 GELATIN INACTIVE INGREDIENT 2G86QN327L AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 SODIUM CITRATE, UNSPECIFIED FORM INACTIVE INGREDIENT 1Q73Q2JULR AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 SODIUM PROPIONATE INACTIVE INGREDIENT DK6Y9P42IN AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 SUCROSE INACTIVE INGREDIENT C151H8M554 AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP AMPICILLIN CAPSULE AMPICILLIN SUSPENSION [DAVA PHARMACEUTICALS, INC.] 4